UPenn researchers find that acupuncture improves quality of life for breast cancer patients using aromatase inhibitors
- Posted: July 30, 2014
Use of electroacupuncture (EA) produces significant improvements in fatigue, anxiety and depression in as little as eight weeks for early stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors to treat breast cancer. The study is the first demonstration of EA's efficacy for both joint pain relief, as well as these other common symptoms.
Click here to read the full press release.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.